As of Apr 29
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 9.86, with a high estimate of 9.86 and a low estimate of 9.86. The median estimate represents a +43.94% increase from the last price of 6.85.
The current consensus among 1 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.